P-Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer-Reference-Cited by-同舟云学术

P-Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer

Published:2015-01 Issue:1 Volume:29 Page:1-6
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Mealey K.L.¹,Fidel J.

Affiliation:

1. Program in Individualized Medicine (PrIMe); Department of Veterinary Clinical Sciences; College of Veterinary Medicine; Washington State University; Pullman WA

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvim.12525/fullpdf

Reference49 articles.

1. Systems analysis of adverse drug events. ADE Prevention Study Group;Leape;J Am Med Assoc,1995

2. Suspected adverse drug events requiring emergency department visits or hospital admissions;Raschetti;Eur J Clin Pharmacol,1999

3. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies;Lazarou;J Am Med Assoc,1998

4. Concise review: Clinical relevance of drug-drug and herb-drug interactions mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein);Marchetti;Oncologist,2007

5. Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense;Leslie;Toxicol Appl Pharmacol,2005

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling mechanisms of chemotherapy-induced peripheral neuropathy and chemotherapy transport using induced pluripotent stem cell-derived sensory neurons;Neuropharmacology;2024-11

2. Prediction of cancer drug combinations based on multidrug learning and cancer expression information injection;Future Generation Computer Systems;2024-11

3. Inhibitory Effect of the Multi-target TKI, Anlotinib, in 5-FU Resistant Colorectal Cancer HCT-8/15 Cells: Down Regulation of Drug Resistance-associated Protein Expression.;2024-06-05

4. Multidrug resistance 1 (MDR1) gene mutation in dogs;The Veterinary Nurse;2024-06-02

5. Disruption of Oncogenic MCL-1-BAX/BAK Interaction Using Integrase Inhibitors: Insights from a Molecular Docking and Dynamic Exploration;2024-05-22